BioNTech appoints Sobi's Guido Oelkers as new CEO, to start by Feb 1 2027
read at Endpoints ↗Neutral
BioNTech announced that Guido Oelkers, currently a leader at Swedish biotech company Sobi, will become its next chief executive officer.
Oelkers is expected to take over the role no later than February 1, 2027.
Sobi said it will begin looking for a replacement for Oelkers following his departure.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “BioNTech names Sobi's Guido Oelkers as incoming CEO”
read at Endpoints ↗80 words · retrieved Aug 3
comments(0)
5-min edit window · permanent after that